| Application no. and date | 11799979.7 (espacenet) (Federated) (European Patent Register), 20110630 | | Patent/reg. no. and date | DK/EP 2588113, 20161214 | | Publication date | 20130508 | | Priority no. and date | US 359925 P, 20100630 | | EP pub. no. and date |
EP 2588113 20130508 | | Effective date | | | Applicant/owner | CSL Limited, 45 Poplar Road
Parkville VIC 3052, AU | | Applicant ref. no. | P22483DKEP | | Inventor | WRIGHT, Samuel, 516 Hillside Avenue
Westfield
New Jersey 07090, US,
IMBODEN, Martin, Schlossmatte 4
CH-3110 Munsingen, CH,
BOLLI, Reinhard, Bellevuestrasse 14
CH-3073 Guemlingen, CH,
WAELCHLI, Marcel, Wohlhausenweg 2D
CH-3645 Gwatt, CH | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/56 (2006.01) , A61K 31/685 (2006.01) , A61K 38/17 (2006.01) , A61P 3/06 (2006.01) , A61P 9/10 (2006.01) | | Title | REKONSTITUERET HØJDENSITETS-LIPOPROTEIN-FORMULERING
SAMT FREMGANGSMÅDE TIL FREMSTILLING AF DEN | | Int. application no. | AU2011000819 | | Int. publication no. | WO2012000048 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
